Application of Neoadjuvant Immuno-chemotherapy in NSCLC
Even patients after standard surgery and adjuvant chemotherapy still have a high risk of recurrence and metastasis. With the success of immunotherapy in advanced non-small cell lung cancer (NSCLC), the application of immunotherapy in locally advanced NSCLC has being investigated to reduce the recurr...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-04-01
|
| Seri Bilgileri: | Chinese Journal of Lung Cancer |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.10 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|